Chinese seek transplants and fertility treatment in Taiwan


Known as offering excellent quality treatment and care, Taiwan’s medical tourism business is on the up.

Transplants are a key sector, such as the liver transplant team at the Kaohsiung branch of Chang Gung Memorial Hospital in Southern Taiwan. The team performed Asia’s first successful liver transplant in 1984, and set a world record in 1997 when it accomplished the first living donor transplant without blood transfusion. With 1500 transplants done, even better news was one- and five-year survival rates of 96 % and 91 % respectively, among the best in the world.

At the Heart Centre of Taipei City-based Cheng Hsin General Hospital, a team performed the world’s first case of artificial heart implementation followed by successful heart and kidney transplants in 1996. It has completed 454 successful transplants, and its five-year survival rate of 74% is one of the highest in the world.

Craniofacial reconstruction is another specialist area, led by the Chang Gung Craniofacial Research Centre in northern Taiwan’s Taoyuan City. Since its establishment in 1981, it has treated 30,000 patients with cleft lip and palate, with a success rate of 100 %.

Taiwan also offers cosmetic surgery, cardiovascular treatment, dental implants, health checks and joint replacements. These affordable services are proving increasingly popular with patients from overseas.

Ministry of Health and Welfare statistics show Taiwan welcomed 305,045 medical tourists in 2015, up 76% from 2012, with revenue of US$491 million up by 65%. Almost all these are from China.

Since China relaxed its one-child policy last year, fertilisation clinics in Taiwan are seeing increased demand from China.

Taiwan’s Chang Gung Hospital has set up an office in Xiamen, Southeast China, to attract cross-strait treatment referrals for future Chinese mothers and offer local treatment. The most sought-after services are fertility treatment, liver transplants and treatment for children suffering from cancer. It is the only hospital providing cross-strait referral for proton therapy – an alternative type of radiation used in cancer treatment.

Last October, the Chinese government relaxed its one-child policy, allowing couples to have a second child. Some women seeking another child soon sought medical advice. IVF (in vitro fertilization) is the most popular treatment option. Since the change in policy, the number of women asking for such help has increased and the average patient age has climbed from 35 to 40. Age is a major factor in a woman's ability to become pregnant. With the biological clock ticking for many of them, more Chinese are seeking fertility treatment at hospitals in Taiwan, as they do not have time for failure.

Taiwan is known worldwide for the high quality of its fertility services, especially IVF treatment. The success rate of IVF in Taiwan is t 40% to 60%, close to that of the Sarthe price of the treatment in Taiwan ranges US$4,600 to US$9,000,about half of the price in Singapore, Hong Kong and China, and much cheaper than in the USA.

The biggest attraction for Chinese parents going to Taiwan for IVF treatment is that there are no language barriers, making the experience much less problematic for them.



Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.


Related News

China’s outbound fertility travel

17 January, 2020

Single Chinese women seeking sperm donors abroad

Largest IVF clinic in SE Europe

17 January, 2020

Large fertility and IVF centre opens in Greece

UAE outbound medical travel

10 January, 2020

Is the patient flow reversing for the UAE?

India’s medical travel awards

09 January, 2020

FICCI identifies leaders in India’s medical travel sector

Inbound Dubai medical travel target

09 January, 2020

xDubai targets 500,000 medical tourists by 2021